AMICUS THERAPEUTICS, INC. financial data

Symbol
FOLD on Nasdaq
Location
Princeton, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 20 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 306% % -0.35%
Quick Ratio 92% % 50%
Debt-to-equity 279% % -26%
Return On Equity -12% % 66%
Return On Assets -3.2% % 57%
Operating Margin 5.2% % 9.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 314,000,712 shares 4.6%
Common Stock, Shares, Outstanding 310,853,963 shares 4%
Entity Public Float $1,744,699,397 USD -41%
Common Stock, Value, Issued $3,037,000 USD 3.2%
Weighted Average Number of Shares Outstanding, Basic 308,363,768 shares 1.3%
Weighted Average Number of Shares Outstanding, Diluted 308,363,768 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $634,210,000 USD 20%
Operating Income (Loss) $32,789,000 USD 32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $191,000 USD -60%
Income Tax Expense (Benefit) $27,301,000 USD -0.18%
Net Income (Loss) Attributable to Parent $27,110,000 USD 52%
Earnings Per Share, Basic -0.09 USD/shares 50%
Earnings Per Share, Diluted -0.09 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $214,010,000 USD 0.12%
Marketable Securities, Current $79,526,000 USD 120%
Accounts Receivable, after Allowance for Credit Loss, Current $115,307,000 USD 14%
Inventory, Net $228,819,000 USD 93%
Assets, Current $676,173,000 USD 34%
Property, Plant and Equipment, Net $27,108,000 USD -7.7%
Operating Lease, Right-of-Use Asset $21,138,000 USD -5.1%
Intangible Assets, Net (Excluding Goodwill) $13,915,000 USD -19%
Goodwill $197,797,000 USD 0%
Other Assets, Noncurrent $13,739,000 USD 0.72%
Assets $949,870,000 USD 21%
Accounts Payable, Current $28,630,000 USD 121%
Employee-related Liabilities, Current $37,682,000 USD 16%
Liabilities, Current $237,828,000 USD 60%
Operating Lease, Liability, Noncurrent $40,962,000 USD -9.1%
Other Liabilities, Noncurrent $4,179,000 USD -41%
Liabilities $675,629,000 USD 14%
Retained Earnings (Accumulated Deficit) $2,767,290,000 USD -0.99%
Stockholders' Equity Attributable to Parent $274,241,000 USD 41%
Liabilities and Equity $949,870,000 USD 21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,758,000 USD
Net Cash Provided by (Used in) Financing Activities $11,700,000 USD 12%
Net Cash Provided by (Used in) Investing Activities $32,861,000 USD -536%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 310,853,963 shares 4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $31,984,000 USD 14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $217,316,000 USD 0.28%
Interest Paid, Excluding Capitalized Interest, Operating Activities $10,852,000 USD -8%
Deferred Tax Assets, Valuation Allowance $622,081,000 USD 2.1%
Deferred Tax Assets, Gross $629,196,000 USD 1.9%
Operating Lease, Liability $49,703,000 USD -7.2%
Payments to Acquire Property, Plant, and Equipment $212,000 USD -88%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $8,096,000 USD 86%
Lessee, Operating Lease, Liability, to be Paid $72,036,000 USD -11%
Property, Plant and Equipment, Gross $58,929,000 USD 1.3%
Operating Lease, Liability, Current $8,741,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,594,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,528,000 USD 0.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.097 pure 0%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21,002,000 USD 309%
Lessee, Operating Lease, Liability, to be Paid, Year Three $9,196,000 USD -2.4%
Deferred Tax Assets, Operating Loss Carryforwards $317,999,000 USD 5.3%
Unrecognized Tax Benefits $21,331,000 USD 55%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,172,000 USD -11%
Depreciation, Depletion and Amortization $7,460,000 USD -13%
Share-based Payment Arrangement, Expense $87,410,000 USD 3%
Interest Expense $50,741,000 USD 24%